More than 11,000 bottles of blood pressure medication recalled, FDA says

More than 11,000 bottles of blood pressure medication recalled, FDA says, in a targeted action tied to drug-release test failures. The U.S. Food and Drug Administration announced that over 11,000 bottles of chlorthalidone tablets are being pulled nationwide because the product failed “dissolution specifications,” meaning it may not dissolve at the correct speed in the body. The FDA said the recall issued on June 22 affects about 11,460 bottles. The medication comes in 25-mg dosage in 100 or 1,000-count bottles, with an expiration date of April 2027, and was voluntarily withdrawn by Inventia Healthcare Limited of India, while Rising Pharma Holdings distributed it across the U.S. Chlorthalidone is a diuretic used to treat high blood pressure. The FDA classified the recall as Class II, indicating temporary or medically reversible adverse effects are possible and the probability of serious harm is remote.